The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee. In 2009.
2.
National Center for Health Statistics. Annual summary of births, marriages, divorces and deaths, United States 1994. Vol. 43. 1995.
3.
Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Vol. 2, The Lancet Neurology. 2003. p. 43–53.
4.
Republička stručna komisija za izradu i implementaciju vodiča dobre kliničke prakse. Ishemijski moždani udar. Nacionalni vodič dobre kliničke prakse. 2011.
5.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Vol. 22, Stroke. 1991. p. 312–8.
6.
Momjian-Mayor I, Baron JC. The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease. Vol. 36, Stroke. 2005. p. 567–77.
7.
Mangla R, Kolar B, Almast J, Ekholm SE. Border Zone Infarcts: Pathophysiologic and Imaging Characteristics. Vol. 31, RadioGraphics. 2011. p. 1201–14.
8.
Damasio H. A Computed Tomographic Guide to the Identification of Cerebral Vascular Territories. Vol. 40, Archives of Neurology. 1983. p. 138–42.
9.
Thygesen K, Alpert JS, White HD. Universal Definition of Myocardial Infarction. Vol. 50, Journal of the American College of Cardiology. 2007. p. 2173–95.
10.
Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack. Vol. 42, Stroke. 2011. p. 227–76.
11.
Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C. Blood pressure and risk of stroke in patients with cerebrovascular disease. Vol. 313, BMJ. 1996. p. 147–147.
12.
Khoury JC, Kleindorfer D, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Diabetes Mellitus. Vol. 44, Stroke. 2013. p. 1500–4.
13.
Shou J, Zhou L, Zhu S, Zhang X. Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta-analysis. Vol. 24, Journal of Stroke and Cerebrovascular Diseases. 2015. p. 1961–8.
14.
Kadoglou NP, Avgerinos ED, Liapis CD. An Update on Markers of Carotid Atherosclerosis in Patients With Type 2 Diabetes. Vol. 4, Biomarkers in Medicine. 2010. p. 601–9.
15.
Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials. Vol. 117, The American Journal of Medicine. 2004. p. 596–606.
16.
Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in Stroke Prevention and Carotid Atherosclerosis. Vol. 35, Stroke. 2004. p. 2902–9.
17.
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Vol. 366, The Lancet. 2005. p. 1267–78.
18.
Eliasson, Agneta Hjalmarson, Elisab B. Effect of smoking reduction and cessation on cardiovascular risk factors. Vol. 3, Nicotine & Tobacco Research. 2001. p. 249–55.
19.
Shaper AG, Phillips AN, Pocock SJ, Walker M, Macfarlane PW. Risk factors for stroke in middle aged British men. Vol. 302, BMJ. 1991. p. 1111–5.
20.
Salazar JD, Wityk RJ, Grega MA, Borowicz LM, Doty JR, Petrofski JA, et al. Stroke after cardiac surgery: short- and long-term outcomes. Vol. 72, The Annals of Thoracic Surgery. 2001. p. 1195–201.
21.
Derdeyn CP, Khosla A, Videen TO, Fritsch SM, Carpenter DL, Grubb RL, et al. Severe Hemodynamic Impairment and Border Zone-Region Infarction. Vol. 220, Radiology. 2001. p. 195–201.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.